Get started
Author

Chun-Wei Chen

CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia
2025 · Xi Qin, Keren Zhou, et al. · Theranostics · 6
PDF
DNMT3A regulates murine megakaryocyte-biased hematopoietic stem cell fate decisions
2025 · Sarah M. Waldvogel, Virginia Camacho, et al. · Blood Advances · 3
SOD1 is a synthetic lethal target in PPM1D -mutant leukemia cells
2023 · Linda Zhang, Joanne I. Hsu, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
CRISPR-tica.ai: A function-informed generative modeling pipeline for prioritizing drug discovery in AML
2025 · Dhvani Vora, Anthony Chan, et al. · Blood · 1
PDF
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
2023 · Linda Zhang, Joanne I Hsu, et al. · eLife · 1
PDF
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
2024 · Linda Zhang, Joanne I Hsu, et al. · eLife
PDF
Author response: SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
2024 · Linda Zhang, Joanne I Hsu, et al. · eLife
Author Response: SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
2024 · Linda Zhang, Joanne I. Hsu, et al. · eLife
PDF
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
2024 · Linda Zhang, Joanne I. Hsu, et al. · eLife
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
2023 · Linda Zhang, Joanne I. Hsu, et al. · eLife
Author Response: SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
2023 · Linda Zhang, Joanne I. Hsu, et al. · eLife
Abstract 2967: ACTR5 maintains hepatocellular carcinoma via H3K9 epigenetic silencing of CDKN2A
2022 · Xiaobao Xu, Lu Yang, et al. · Cancer Research
Effect Observation of Integrated Chinese and Western Medicine in Elderly Rheumatism Patients
2019 · Chun-Wei Chen · Chinese and Foreign Medical Research
Works count: 13
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type